Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Unpredictable Costs: How Will Healthcare Price Inflation Impact Workers’ Comp?

Prices are rising for some healthcare products and services that will likely impact workers' compensation medical care
Summer 2023

A Golden Opportunity: The Physical Therapist’s Role in Behavioral Health

The connection between physical and behavioral health opens an opportunity for physical therapists to address mental health for injured workers.
Summer 2023

Build Your Army: Maintaining Cybersecurity Amid the IT Talent Gap

Considerations to counteract the cybersecurity talent shortage in workers' comp organizations
Summer 2023

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

Pain Points: Chronic Pain and the Injured Worker

Consequences for injured workers and in the workplace, from absenteeism to higher healthcare costs, and more.
Jul 2025

Nevada Enacts Workers’ Comp Formulary

The state will adopt the ODG Drug Formulary by July 1, 2027, with coverage of non-formulary drugs allowed through January 1, 2028.
Jul 2025

CWCI Publishes Report on Long-COVID

Long COVID cases made up 4.7% of COVID claims, totaling 6,000 claims, yet their medical payments totaled $105 million.
Jul 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Xeljanz Could Increase the Risk of Heart Problems and Cancer

New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.
Feb 2021

COVID-19’s Impact on Opioid Prescribing Trends

A new report from IQVIA found that national MME dropped 17% from 2019 to 2020.
Jan 2021

IQVIA Reports on Telemedicine Trends and Opportunities

A new report explores how COVID-19 has impacted telemedicine, as well as opportunities for expansion.
Dec 2020
1 … 11 12 13 14 15 … 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle